Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Device arm
Sham arm
Sponsored by

About this trial
This is an interventional treatment trial for Obesity
Eligibility Criteria
Inclusion Criteria:
- Aged over 18 years,
- BMI > 30 and < 36 kg/m2, with or without comorbidities,
- BMI > 36 and < 40 without comorbidities
Exclusion Criteria:
- Previous gastric surgery
- Taking anticoagulant drugs
- Psychiatric disorders
- Severe esophagitis
Sites / Locations
- Faculty of Medicine of ABC
- Kaiser Clinic and Day Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Device arm
Sham arm
Arm Description
Gastric endosuturing will be performed until the entire gastric body is sutured in the form of a tube.
Group II is a control group (only the endoscopist will know which group each patient belongs to)
Outcomes
Primary Outcome Measures
Weight loss
weight in kg
Secondary Outcome Measures
Weight maintenance
weight in kg
Surgical related complications
Comorbidities
Full Information
NCT ID
NCT03493620
First Posted
March 14, 2018
Last Updated
August 16, 2022
Sponsor
Kaiser Clinic and Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03493620
Brief Title
Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
Official Title
Multicenter Randomized Prospective Study With Sham Group to Evaluate the Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
January 8, 2018 (Actual)
Primary Completion Date
August 1, 2019 (Actual)
Study Completion Date
August 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Clinic and Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Obesity is a chronic disease that has grown to epidemic proportions in Brazil and throughout the world in recent years. Bariatric surgery has been the most effective method for the treatment and prophylaxis of complications caused by morbid obesity, thereby increasing the longevity and quality of life of patients. The treatment of patients with Class III obesity or higher or Class II with comorbidities is already well established with bariatric surgery being the best option. However, there is no consensus as to the best treatment in cases of Class I or II obesity without comorbidities. The objective of this research will be to make a gastric tube similar to that obtained by surgical gastroplication but using endoscopic intragastric sutures.
Detailed Description
The primary objective of this research will be to make a gastric tube similar to that obtained by surgical gastroplication but using endoscopic intragastric sutures. The secondary objective will be to correlate demographic, endoscopic and laboratory data with the outcomes.
This study will be carried out in two institutions. The Kaiser Clinic and Day Hospital and the Faculty of Medicine of ABC. Sixty patients will be randomly selected for treatment by Endospore Endoscopy (ESG) or as controls (only the endoscopist will know which group each patient belongs to). The draw will take place only after upper endoscopy has been carried out to avoid possible contraindications for the procedure due to injuries. Once the criteria for endoscopic evaluation have been met, randomization will be carried out in loco with the patient still sedated. Gastric Endo Sutures will be performed when the patient is randomized for Group I; Group II will be the control group. All patients will be followed up for two years by a multidisciplinary team (endoscopist, surgeon, nutritionist and psychologist). The data will be obtained during the outpatient follow-up at the Hospital Mario Covas and will include demographic (gender, age), clinical (height, weight, BMI, time after procedure, hypertension, diabetes, dyslipidemia, smoking, alcoholism) and operative data (complications).
Preparation to perform the examination/procedure: All exams will be performed with the patients within eight hours. The procedure will begin with the patient in left lateral decubitus position and under general anesthesia performed by an anesthesiologist. Endoscopic suturing will be performed with 2-0 prolene stitches until a tubular-shaped stomach is formed similar to vertical gastrectomy.
Recovery after the procedure: After this procedure and recovery from the anesthesia, all patients will only be discharged in the company of a companion. All patients will be counseled to enter in touch with the physician to report any signs or symptoms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Device arm
Arm Type
Experimental
Arm Description
Gastric endosuturing will be performed until the entire gastric body is sutured in the form of a tube.
Arm Title
Sham arm
Arm Type
Sham Comparator
Arm Description
Group II is a control group (only the endoscopist will know which group each patient belongs to)
Intervention Type
Procedure
Intervention Name(s)
Device arm
Intervention Description
Make a gastric tube (endoscopic sleeve gastroplasty) using the Apollo Overstitch suturing device through endoscopy.
Intervention Type
Procedure
Intervention Name(s)
Sham arm
Intervention Description
Group II will be conducted identically to Group I except for the procedure itself, and only the endoscopist, that is the researcher, will be aware of which group each patient belongs to.
Primary Outcome Measure Information:
Title
Weight loss
Description
weight in kg
Time Frame
outcome will be evaluated for 2 years
Secondary Outcome Measure Information:
Title
Weight maintenance
Description
weight in kg
Time Frame
2 years
Title
Surgical related complications
Time Frame
2 years
Title
Comorbidities
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged over 18 years,
BMI > 30 and < 36 kg/m2, with or without comorbidities,
BMI > 36 and < 40 without comorbidities
Exclusion Criteria:
Previous gastric surgery
Taking anticoagulant drugs
Psychiatric disorders
Severe esophagitis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luiz Gustavo de Quadros, MD
Organizational Affiliation
Kaiser Clinica and Day Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Eduardo Grecco, MD
Organizational Affiliation
ABC Medical School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Manoel Galvao Neto, MD
Organizational Affiliation
ABC Medical School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thiago Ferreira de Souza, PhD
Organizational Affiliation
ABC Medical School
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Medicine of ABC
City
Santo André
State/Province
SP
Country
Brazil
Facility Name
Kaiser Clinic and Day Hospital
City
São José Do Rio Preto
State/Province
SP
Country
Brazil
12. IPD Sharing Statement
Learn more about this trial
Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
We'll reach out to this number within 24 hrs